Attached files
file | filename |
---|---|
10-Q - QUARTERLY REPORT - MEDICAL MAKEOVER CORP OF AMERICA | f10q0909_medicalmake.htm |
EX-31.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF SARBANES-OXLEY - MEDICAL MAKEOVER CORP OF AMERICA | f10q0909ex31_medicalmake.htm |
EX-31.2 - CERTIFICATION OF THE ACTING CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF - MEDICAL MAKEOVER CORP OF AMERICA | f10q0909ex31ii_medicalmake.htm |
EX-32.2 - CERTIFICATION ACTING CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF SARBANES- - MEDICAL MAKEOVER CORP OF AMERICA | f10q0909ex32ii_medicalmake.htm |
EXHIBIT
32.1
CERTIFICATION
OF CHIEF EXECUTIVE OFFICER
PURSUANT
TO
18 U.S.C.
SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
I, Jason
Smart, Chief Executive Officer of
Makeover Corporation of
America (the
"Company"), hereby certify, pursuant to 18
U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that, to my knowledge:
(1)
The Company's Quarterly Report on Form 10-Q for
the quarter ended September 30, 2009, as filed with the Securities
and Exchange Commission on the date hereof
(the "Report"), fully complies with
the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The information contained in
the Report fairly presents, in all
material respects, the financial condition and
results of operations of the Company.
/s/ Jason Smart
Jason
Smart
Chief Executive
Officer
Date:
November 12, 2009
-------------------
This certification accompanies the Report pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.
A
signed original of this
written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of
this written statement required by Section 906, has
been provided to the Company and will be retained by the Company and
furnished to the Securities and
Exchange Commission or its staff upon request.